Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its efficacy to immune checkpoint inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its efficacy to immune checkpoint inhibitors

Published:2024-09 Issue: Volume:209 Page:114260
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Xie Mengqing,Chu Tianqing,Dong Xiaorong,Wang Huijuan,Chu Qian,Cai Xiuyu,Wang Jialei,Yao Yu,Wu Lin,Ye Feng,Zhu Bo,Zhou Caicun,Su Chunxia

Funder

National Natural Science Foundation of China

National Aerospace Science Foundation of China

Shanghai Shenkang Hospital Development Center

Shanghai Shen Kang Hospital Development Center

Publisher

Elsevier BV

Reference29 articles.

1. Characteristics and clinical outcomes of sarcomatoid carcinoma of the lung;Ung;Clin Lung Cancer,2016

2. Outcomes of sarcomatoid carcinoma of the lung: a surveillance, epidemiology, and end results database analysis;Yendamuri;Surgery,2012

3. Best practices recommendations for diagnostic immunohistochemistry in lung cancer;Yatabe;J Thorac Oncol,2019

4. Board. WCoTE. WHO classification of tumours. 2021.

5. Clinical analysis of 95 cases of pulmonary sarcomatoid carcinoma;Gu;Biomed Pharm,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP